Phadia Ab is recalling approximately 124,928 EliA GBM Wells (Material Number 14551401) used with Phadia 250, 2500, and 5000 laboratory systems. These diagnostic test kits, which are used to detect specific antibodies in patient samples, have been found to produce false positive results even when the required antigen is not present. This defect was identified following complaints that certain samples showed reactivity to the coating solution itself rather than the intended target.
A false positive result for GBM (Glomerular Basement Membrane) antibodies could lead to an incorrect diagnosis of serious conditions like Goodpasture syndrome, potentially resulting in patients receiving unnecessary and aggressive medical treatments or undergoing invasive procedures.
Manufacturer Notification and Guidance
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.